Skip to contentSkip to filters

We use cookies for analytics.

Topic: APP/PS1

ePoster
10 ePosters

In Neuroscience

ePoster · Neuroscience

Assessment of gradual perceptual learning by behaviour and neuron-glia imaging in AD model mice

Philip Gade Knak, Rune Nguyen Rasmussen, Tatsushi Yokoyama, Masayuki Sakamoto, Maiken Nedergaard, Hajime Hirase, Antonis Asiminas · FENS Forum 2024

Understanding the cellular mechanisms underlying learning and their alteration in Alzheimer’s disease (AD) is crucial for developing targeted therapies. We aimed to elucidate coordinated astrocytic and neuronal activities in learning, with a specific focus on their dynamics influenced by experience and alterations in AD. Using calcium imaging of neurons and astrocytes in the APP/PS1 double transgenic Alzheimer’s disease mouse model, we investigated behavioural and cellular responses to repetitive visual stimuli, in comparison with littermate wild type (WT) mice.We collected data from 32 female

ePoster · Neuroscience

The effect of ergothioneine on synaptic plasticity in the hippocampal CA1 region using Alzheimer’s disease mouse model

Suk Yin Lee, Irwin Cheah, Barry Halliwell, Sajikumar Sreedharan · FENS Forum 2024

Studies have shown that ergothioneine (ergo), a derivative of histidine synthesized by certain fungi and actinobacteria, can protect against neuronal injury induced by exogenous Aβ. Our aim is to investigate the role of ergo in synaptic plasticity using the AD mouse model. Field electrophysiology was performed in the CA1 region of hippocampal slices from male C57BL/6 mice to measure synaptic modification over time. Hippocampal slices from the double transgenic AD mouse model APP/PS1, when stimulated with a strong tetanisation protocol, exhibit impaired late long-term potentiation (late-LTP), w

Heat shock proteins (HSPs) are evolutionarily conserved chaperones. Previously our group observed that overexpression of HSPB1 improved certain symptoms of Alzheimer’s disease (AD) in mice. The primary role of these chaperons is to maintain the protein homeostasis, however, several evidence suggest that they have additional functions, such as regulating inflammation. Therefore, our aim is to investigate the role of HSPB1 in chronic neuroinflammation and glia activation in a mouse model of AD.AD model (APP/PS1) mouse strain was crossed with an HSPB1 overexpressing line. Expression pattern of HS

ePoster · Neuroscience

Evaluation of CA3 place cell remapping in the APP/PS1 model mouse of Alzheimer’s disease

Eva Maria Robles Hernandez, Solène Escoffier, Maxi Blei, Jill Dorozalla, Rina Patel, Matthias Haberl, Silvia Viana da Silva · FENS Forum 2024

Spatial navigation impairments are among the earliest clinical manifestations of Alzheimer’s Disease (AD). Pyramidal cells of the hippocampus fire selectively when the animal is in a specific location in the environment, leading to the theory that the hippocampus plays a crucial role in forming a cognitive map of the environment. The phenomenon of “remapping”, where specific cells exhibit selective firing in distinct environments, is thought to support the formation of different memories. By performing in-vivo electrophysiological recordings in freely moving mice while they navigate through di

ePoster · Neuroscience

Receptor Protein Tyrosine Phosphatase β/ζ regulates high-fat diet-induced deleterious cognitive effects and Aβ plaque formation in APP/PS1 mice

Teresa Fontán-Baselga, Héctor Cañeque-Rufo, Elisa Rivera-Illades, Esther Gramage, José María Zapico, Beatriz de Pascual-Teresa, Gonzalo Herradón, Marta Vicente-Rodríguez · FENS Forum 2024

Obesity is linked to neurodegenerative diseases through neuroinflammation. Pleiotrophin (PTN) is a cytokine that is upregulated in different neuroinflammatory disorders of diverse origin. PTN is a ligand and an endogenous inhibitor of Receptor Protein Tyrosine Phosphatase (RPTP) β/ζ. To investigate the role of RPTP β/ζ, in neuroinflammation and neurodegeneration, we used the APP/PS1 genetic model of Alzheimer disease (AD) and a high-fat diet (HFD)-induced obesity model. Three-month-old wild type (WT) mice were fed with standard chow or HFD (60 Kcal % fat) for three months. MY10, an exogenous R

ePoster · Neuroscience

The steroid sulfatase inhibitor STX64 improves mice cognitive deficiencies associated with aging

Juan Antonio Fernández Cabrera, Inés Sánchez Romero, José Manuel Hernández Curiel, M Mercedes Pérez Jiménez, Manuel Jesús Muñoz Ruiz, Ángel Manuel Carrión Rodríguez · FENS Forum 2024

Aging produces in brain a progressive oxidative process and neuroinflammation that deteriorates cognition. These brain dysfunctions provoke high economic and social costs to developed societies. For this reason, the search for treatments to prevent cognitive deficits associated with aging is a priority. Previous results suggest that STX64, a steroid sulfatase (STS) inhibitor, improves cognition in neurodegenerative diseases. In this work, we have designed cellular (immunohistochemistry), molecular (qPCRs with primers of inflammatory markers and cellular populations) and behaviour (mainly, obje

ePoster · Neuroscience

Structural and functional alterations in the retina of a model of Alzheimer’s disease and type 2 diabetes

Angel del Marco, Santiago Milla-Navarro, Karis Little, Maria Llorián-Salvador, Fátima Cano-Cano, Rafael Simó, Alan W Stitt, Pedro de la Villa, Monica Garcia-Alloza · FENS Forum 2024

The retina, as part of the central nervous system, shows abnormalities in Alzheimer`s disease (AD) and type 2 diabetes (T2D). Importantly, analysis of the retina may provide a non-invasive approach with diagnostic and prognostic value for cognitive decline. In addition, T2D increases risk to suffer AD. Accordingly, we have analyzed structural and functional alterations, by spectral domain optical coherence tomography and electroretinography (ERG) respectively, in the retina from APP/PS1 (AD model), db/db (T2D model) and APP/PS1xdb/db (AD-T2D model) animals at 4 weeks of age, before the onset o

ePoster · Neuroscience

Study of excitatory/inhibitory balance in the hippocampus of a transgenic mouse model of Alzheimer disease

Floriane Payet, Sylvie Boisseau, Alain Buisson, Fabien Lanté · FENS Forum 2024

Alzheimer's disease (AD) is the most common form of dementia after the age of 65. Prior to cognitive impairment, this disease is characterized by a long asymptomatic phase during which dysfunctions of neurotransmission have been demonstrated. It is known that these early dysfunctions are the result of an abnormal accumulation of β-amyloid peptide which accumulates in different regions of the brain, notably the hippocampus. By performing electrophysiological recordings on the APP/PS1 transgenic mouse model that show an overproduction of β-amyloid peptide, I identified an alteration of the inhib

ePoster · Neuroscience

Subpopulations of hippocampal inhibitory interneurons contribute differently to engram formation in APP/PS1 mice

William Fernandes Paes de Barros, Miguel De Castro Vera Cruz Vieira, Shimon Jude Swer, Camin Dean, Silvia Viana da Silva, Matthias Haberl · FENS Forum 2024

Understanding the neural mechanisms underlying memory formation and retrieval is fundamental to unraveling the pathophysiology of Alzheimer's disease (AD). Inhibitory interneurons have fundamental roles in shaping neural circuits and synaptic plasticity within the hippocampus, a brain region critical for memory encoding and consolidation. However, the specific contribution of inhibitory interneurons to the formation and maintenance of engrams, the neural representations of memories, remains poorly understood, particularly in the context of AD.To determine neurons participating in the engram fo

ePoster · Neuroscience

Type one diabetes modifies tau phosphorylation patterns and worsens cognitive impairment in the APP/PS1 mouse model of Alzheimer’s disease

Miriam Corraliza-Gomez, Maria Vargas-Soria, Carmen Infante-Garcia, Alan W. Stitt, Rafael Simó, Mónica García-Alloza · FENS Forum 2024

Alzheimer’s disease (AD) is the most common cause of dementia. Despite age being the main risk factor, previous studies have also reported that type 1 diabetes (T1D) may contribute to abnormal tau phosphorylation and worsen cognitive impairment in AD patients. However, the underlying mechanisms are not completely understood. Therefore, we have analyzed the effects of streptozotocin (STZ)-induced T1D in a mouse model of AD (APP/PS1) in terms of metabolic impairment, cortical tau phosphorylation and cognition at 26 weeks of age, when the pathology is fully established. When all groups under stud